InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-12.9%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by GEMAYEL GEORGES, Director. Insider active across 1 company, notably Supernus Pharmaceuticals, INC.. Aggregated, 9 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €1m. Activity tracked since 19 February 2022. The latest transaction was disclosed on 5 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
10,000 shares@ US$53.710.017% mcap50.0% of flowCommon StockSEC:0001256088-26-000006
10,000 shares@ US$53.710.016% mcap50.0% of flowCommon StockSEC:0001256088-26-000006:0
5,369 shares0Common StockSEC:0001628280-25-007463:0
10,787 shares@ US$11.468.8% of flowCommon StockSEC:0001628280-24-047145:0
14,213 shares@ US$11.4611.7% of flowCommon StockSEC:0001628280-24-046666:0
3,886 shares@ US$31.338.5% of flowCommon StockSEC:0001628280-24-040598:0
3,886 shares0Common StockSEC:0001104659-24-028279:0
3,882 shares0Common StockSEC:0001104659-23-025380:0
4,222 shares0Common StockSEC:0001104659-22-026103:0
9 of 9 declarations
About GEMAYEL GEORGES
Georges Gemayel is a Board Member at Supernus Pharmaceuticals, Inc. He provides expertise in corporate governance and strategy. His role on the board is essential for guiding strategic decisions and ensuring the company's regulatory compliance. Georges Gemayel is recognized for his ability to analyze market trends and advise on best management practices.
